2018
DOI: 10.1177/1556264618771809
|View full text |Cite
|
Sign up to set email alerts
|

The Ethics of End-of-Trial Obligations in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania

Abstract: This study explores stakeholder experiences and perspectives on end-of-trial obligations at the close of a phase II/III Pediatric Malaria Vaccine Trial (PMVT) [GSK/PATH-MVI RTS, S) (NCT00866619]. We conducted 52 key informant interviews with major stakeholders of an international multicentre PMVT in Ghana and Tanzania. The responses fell into four main themes: (a) Communicating End-of-Trial, (b) Maintaining Health Care Services, (c) Dissemination of Results, and (d) Post-Trial Access. Interviewee responses sha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…Taking this finding seriously suggests that more attention could be given to how the resources accompanying health research trials - which can include the strengthening of local health infrastructure, staffing, surveillance, diagnostics and supplies - can potentially strengthen health systems. This could be reflected in more explicit planning and monitoring of this relationship ( Asante et al , 2016 ; Kingori, 2015 ; Ward et al , 2018 ) so that health research maximises the opportunities to strengthen local health systems and minimizes the danger of undermining them. At the same time, the relationships that CE facilitates provide an opportunity to mitigate the ethical challenges of the current dominant research paradigm; by building upon and strengthening their collaborative character further to broker better integration of health research and health systems strengthening.…”
Section: Discussionmentioning
confidence: 99%
“…Taking this finding seriously suggests that more attention could be given to how the resources accompanying health research trials - which can include the strengthening of local health infrastructure, staffing, surveillance, diagnostics and supplies - can potentially strengthen health systems. This could be reflected in more explicit planning and monitoring of this relationship ( Asante et al , 2016 ; Kingori, 2015 ; Ward et al , 2018 ) so that health research maximises the opportunities to strengthen local health systems and minimizes the danger of undermining them. At the same time, the relationships that CE facilitates provide an opportunity to mitigate the ethical challenges of the current dominant research paradigm; by building upon and strengthening their collaborative character further to broker better integration of health research and health systems strengthening.…”
Section: Discussionmentioning
confidence: 99%
“…The RTS, S is the first and only vaccine that has currently proven to significantly reduce malaria infection with an acceptable safety profile [ 16 , 17 ]. The vaccine is intended to be delivered as part of the Expanded Programme on Immunizations (EPI).…”
Section: Introductionmentioning
confidence: 99%
“…The idea that involvement in clinical research can develop local capacity has been proposed elsewhere (Chetwood et al, 2015; World Health Organization [WHO], 2012), along with the myriad of challenges faced by researchers in sub-Saharan Africa (Mwangoka et al, 2013). Common themes have emerged among stakeholders, such as the need for equitable partnerships entailing the respect for the needs, interests, and agendas of all partners; addressing the barriers and opportunities to sustain system capacity; addressing local health targets; and regional commitment to benefit sharing (Ogundahunsi, 2016; Ward, 2017), along with communicating end-of-trial information and disseminating study results (Ward 2018).…”
Section: Introductionmentioning
confidence: 99%